Adams Chetwood Wealth Management’s Precision BioSciences DTIL Stock Holding History

Adams Chetwood Wealth Management’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$441K	Sell	4,769 -7	-0.1%	-$951	0.25%	59
2021 Q4	$1.06M	Sell	4,776 -1,230	-20%	-$344K	0.72%	33
2021 Q3	$2.08M	Hold	6,006	–	–	1.51%	17
2021 Q2	$2.26M	Hold	6,006	–	–	1.59%	15
2021 Q1	$1.86M	Sell	6,006 -2,026	-25%	-$709K	1.42%	17
2020 Q4	$2.01M	Sell	8,032 -3,135	-28%	-$768K	1.67%	12
2020 Q3	$2.06M	Sell	11,167 -6,667	-37%	-$1.33M	1.99%	11
2020 Q2	$4.46M	Sell	17,834 -1,333	-7%	-$292K	4.53%	4
2020 Q1	$4.32M	Sell	19,167 -4,777	-20%	-$1.25M	5.06%	4
2019 Q4	$9.98M	Buy	+23,944	New	+$7.52M	10.21%	3

Other funds holding DTIL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OMC

OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Adams Chetwood Wealth Management's DTIL Position: Q1 2022 in Review

Adams Chetwood Wealth Management reduced its Precision BioSciences (DTIL) stake by 0.15% in Q1 2022, selling an estimated $951 and leaving 4,769 shares worth $441K. The position accounts for 0.25% of the portfolio, ranked #59.

Adams Chetwood Wealth Management first reported a position in DTIL in Q4 2019 and has held it in 10 quarters since. The position peaked at $9.98M in Q4 2019. 152 funds tracked by Wall St. Rank hold DTIL as of Q1 2022.

Adams Chetwood Wealth Management held 4,769 shares of Precision BioSciences worth $441K as of Q1 2022.
Adams Chetwood Wealth Management sold 7 Precision BioSciences shares in Q1 2022, an estimated $951.
Precision BioSciences made up 0.25% of Adams Chetwood Wealth Management's portfolio in Q1 2022, its #59 holding.
Adams Chetwood Wealth Management first reported a position in Precision BioSciences in Q4 2019 and has held it in 10 quarters since.
Adams Chetwood Wealth Management's Precision BioSciences position peaked at $9.98M in Q4 2019.
152 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2022.

Based on Adams Chetwood Wealth Management's 13F filing for Q1 2022, filed 13 Apr 2022.